Obtains proof of concept for a renal rehabilitation app for patients with chronic kidney disease
First written in FY2022-Q2. 10 of 14 entries say "Restated". Latest entry: 2026-08-07.
No other company in this theme has enough history to compare yet.
- FY2026-H1RestatedAnnual report
「For the renal rehabilitation app for patients with chronic kidney disease, we have completed the exploratory study (equivalent to a Phase II clinical trial) and are preparing for the next study.」
The company remains at the stage of proceeding with preparations for the next study after completing the exploratory study. - FY2025-H1AdvancedAnnual report
「The renal rehabilitation app for patients with chronic kidney disease has also completed an exploratory study equivalent to a Phase II clinical trial, and preparations are under way for the next study.」
The company states that, after completing the exploratory study, the app has progressed to the preparation stage for the next study. - FY2024-Q3AdvancedAnnual report
「For the other pipelines, development is also progressing smoothly, with the renal rehabilitation app for patients with chronic kidney disease and the app supporting advance care planning for patients with advanced cancer having completed exploratory studies equivalent to Phase II clinical trials.」
The renal rehabilitation app for patients with chronic kidney disease has progressed from the stage of completing subject enrollment in its exploratory study to the stage of completing the study. - FY2024-Q2RestatedAnnual report
「Development is progressing smoothly, with subject enrollment completed in exploratory studies equivalent to Phase II clinical trials for both the app supporting advance care planning for patients with advanced cancer and the renal rehabilitation app for patients with chronic kidney disease.」
The renal rehabilitation app for patients with chronic kidney disease continues to have subject enrollment completed in its exploratory study. - FY2024-Q1RestatedAnnual report
「For the app supporting advance care planning for patients with advanced cancer and the renal rehabilitation app for patients with chronic kidney disease, subject enrollment has been completed in exploratory studies equivalent to Phase II clinical trials, respectively.」
The company continues to describe the renal rehabilitation app for patients with chronic kidney disease as having completed subject enrollment in its exploratory study. - FY2023RestatedAnnual report
「The company is jointly developing a therapeutic app that provides exercise therapy for patients with chronic kidney disease with Tohoku University and the Japanese Society of Renal Rehabilitation.」
The company continues the joint development of the renal rehabilitation app for patients with chronic kidney disease. - FY2023-Q3AdvancedAnnual report
「For the other pipelines, subject enrollment has also been completed in an exploratory study to obtain proof of concept (PoC) for an app supporting advance care planning and in an exploratory study of a renal rehabilitation app for patients with chronic kidney disease.」
The renal rehabilitation app for patients with chronic kidney disease has progressed from the preparation stage of its exploratory study to the stage of completing subject enrollment. - FY2023-Q2RestatedAnnual report
「The company is preparing an exploratory study of the renal rehabilitation app for patients with chronic kidney disease.」
The renal rehabilitation app for patients with chronic kidney disease remains in the preparation stage for an exploratory study. - FY2023-Q1RestatedAnnual report
「The company is preparing a clinical trial for the renal rehabilitation app for patients with chronic kidney disease.」
The renal rehabilitation app for patients with chronic kidney disease remains in the preparation stage for a clinical trial. - FY2022RestatedAnnual report
「The company is jointly developing a therapeutic app that provides exercise therapy for patients with chronic kidney disease with Tohoku University and the Japanese Society of Renal Rehabilitation.」
The company continues the joint development of the app for patients with chronic kidney disease and preparations for its clinical trial. - FY2022-Q3RestatedAnnual report
「For the renal rehabilitation app for patients with chronic kidney disease, preparations are being made for an exploratory study to obtain proof of concept (PoC).」
The renal rehabilitation app remains in the preparation stage for an exploratory study. - FY2022-Q2First statedAnnual report
「For the renal rehabilitation app for patients with chronic kidney disease, preparations are being made for an exploratory study to obtain proof of concept (PoC).」
The company describes the app as being in the preparation stage for an exploratory study, with proof of concept (PoC) as its objective.